Steglatro Dosage
Generic name: ERTUGLIFLOZIN PIDOLATE 5mg
Dosage form: tablet, film coated
Drug class: SGLT-2 inhibitors
Medically reviewed by Drugs.com. Last updated on Oct 13, 2022.
Prior to Initiation of STEGLATRO
- Assess renal function prior to initiation of STEGLATRO and as clinically indicated [see Warnings and Precautions (5.3)].
- In patients with volume depletion, correct this condition before initiating STEGLATRO [see Warnings and Precautions (5.3), Use in Specific Populations (8.5, 8.6)].
Recommended Dosage
- The recommended starting dose of STEGLATRO is 5 mg once daily, taken in the morning, with or without food.
- For additional glycemic control, the dose may be increased to 15 mg once daily in patients tolerating STEGLATRO.
- Use of STEGLATRO is not recommended in patients with an eGFR less than 45 mL/min/1.73 m2.
- STEGLATRO is contraindicated in patients on dialysis.
Frequently asked questions
More about Steglatro (ertugliflozin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (11)
- Drug images
- Latest FDA alerts (1)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: SGLT-2 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
